Shift to Novel Biologics and Biologics CDMO Expansion: Key India Biologics Market Trends
Monitoring the latest India Biologics Market Trends reveals a strategic transition beyond the primary focus on biosimilars. The most pronounced trend is the Increasing Investment in Novel Biologics and Advanced Therapies. While biosimilars remain the volume driver, Indian companies and government bodies are actively moving up the value chain by focusing R&D on complex molecules,...
0 Commenti 0 condivisioni 54 Views 0 Anteprima